Evidence map›Paper›PMID 33260254›Full record

SynthesisBJU international2021

Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta-analyses.

Hadi Mostafaei, Keiichiro Mori, Sakineh Hajebrahimi, Mohammad Abufaraj, Pierre I Karakiewicz, Shahrokh F Shariat

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in BJU international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 9 countries.

Hadi MostafaeiDepartment of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-5596-1771
Keiichiro MoriDepartment of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-6147-6569
Sakineh HajebrahimiResearch Centre for Evidence-Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID 0000-0003-1494-7097
Mohammad AbufarajDepartment of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-6603-6319
Pierre I KarakiewiczCancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada.
Shahrokh F ShariatDepartment of Urology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.
Tabriz University of Medical Sciences · IRUniversity of Jordan · JOJikei University School of Medicine · JPMcGill University Health Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo present an overall picture of the evidence regarding the association of erectile dysfunction (ED) with cardiovascular disease (CVD).

methodsSystematic reviews and meta-analyses that studied the association of ED with any CVD were included in this umbrella review. We did not restrict the population to a particular group or age. PubMed, Embase, the Joanna Briggs Institute (JBI) Database of Systematic Reviews and Implementation Reports, the Cochrane Database of Systematic Reviews, the Database of Abstracts of Reviews of Effects, and the PROSPERO register were searched to find relevant systematic reviews, with or without meta-analyses, from inception to April 2020. The JBI Checklist for Systematic Reviews and Research Syntheses was used for the critical appraisal. Only studies with acceptable quality were included. Two independent reviewers extracted the data using the JBI data extraction tool for qualitative and quantitative data extraction.

resultsThe summary estimate showed a higher risk of CVD (relative risk [RR] 1.45, 95% confidence interval [CI] 1.36-1.54; P < 0.001), coronary heart disease (RR 1.50, 95% CI 1.37-1.64; P < 0.001), cardiovascular-related mortality (RR 1.50, 95% CI 1.37-1.64; P < 0.001), all-cause mortality (RR 1.25, 95% CI 1.18-1.32; P < 0.001), myocardial infarction (RR 1.55, 95% CI 1.33-1.80; P < 0.001) and stroke (RR 1.36, 95% CI 1.26-1.46; P < 0.001) in patients with ED than in other patients.

conclusionsOur results confirm that ED is an independent predictor of CVD and their outcomes. ED and CVD are two presentations of the same physiological phenomenon. ED normally precedes symptomatic CVD, providing a window of opportunity for healthcare practitioners to screen and detect high-risk patients early to prevent avoidable morbidity and mortality.

Indexed as

Meta-Analysis as TopicSystematic Reviews as TopicCardiovascular DiseasesErectile DysfunctionHumansMalecardiovascular diseasecoroanary heart disease#erectiledysfunctionerectile dysfunctionmyocardial infarctionpreventionumbrella review

Identifiers

PMID33260254
PMCPMC8359379
OpenAlexW3108186240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.